Projects funded by the NCN
Evaluation of primary and secondary molecular disorders determinig drug resistance from a group of proteasome inhibitors (bortezomib, carfilzomib) and other anti myeloma drugs in patients with multiple myeloma
2016/23/B/NZ5/02529
Keywords:
multiple myeloma resistance molecular basis
Descriptors:
- NZ5_5: Diagnostics in human diseases
- NZ5_7: Human disease treatment
- NZ5_9: Other related subjects
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Lekarski
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 4
Call: OPUS 12 - announced on 2016-09-15
Amount awarded: 1 015 564 PLN
Project start date (Y-m-d): 2017-10-01
Project end date (Y-m-d): 2021-12-31
Project duration:: 51 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.